Financials

News Ideas Technicals

2197 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CLOVER BIOPHARMACEUTICALS LTD operating, investing, and financing activities

2197 free cash flow for H2 23 is -318.81 M HKD. For 2023, 2197 free cash flow was -830.28 M HKD and operating cash flow was -822.6 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—